(Institución)
 
 

Docu-menta >

Statistics

Total Visits

Views
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 342

Total Visits per Month

September 2025 October 2025 November 2025 December 2025 January 2026 February 2026 March 2026
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 15 20 22 14 7 9 10

File Downloads

Views
23. Navarro- MOL THERAPY MCD 2021.pdf 194

Top Country Views

Views
España 342

Top City Views

Views
Madrid 342

 

Información y consultas: documenta@ciemat.es | Documento legal